Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goadsby

Showing results (751-760 of 916) with videos related to

Pageof 92
Sort By:
Headache|September 29, 2001
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysisR B Lipton, J Pascual, P J Goadsby, et al.
Cephalalgia : an International Journal of Headache|April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyPeter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
The New England Journal of Medicine|March 12, 2004
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraineJes Olesen, Hans-Christoph Diener, Ingo W Husstedt, et al.
Brain : a Journal of Neurology|July 29, 1998
Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraineA May, S L Shepheard, M Knorr, et al.
Cephalalgia : an International Journal of Headache|February 21, 2025
Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trialsPeter J Goadsby, Tim P Jürgens, Elimor Brand-Schieber, et al.
Headache|March 22, 2021
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysisAndrew M Blumenfeld, Peter J Goadsby, David W Dodick, et al.
Neurology|January 15, 2000
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering CommitteeP J Goadsby, M D Ferrari, J Olesen, et al.
Cephalalgia : an International Journal of Headache|September 7, 2011
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouseRammya Mathew, Anna P Andreou, Linda Chami, et al.
Headache|July 20, 2018
Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.
The Lancet. Neurology|February 21, 2023
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trialRichard B Lipton, Robert Croop, David A Stock, et al.
Pageof 92

Showing results (751-760 of 916) with videos related to

Sort By:
Pageof 92
Headache|September 29, 2001
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysisR B Lipton, J Pascual, P J Goadsby, et al.
Cephalalgia : an International Journal of Headache|April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyPeter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
The New England Journal of Medicine|March 12, 2004
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraineJes Olesen, Hans-Christoph Diener, Ingo W Husstedt, et al.
Brain : a Journal of Neurology|July 29, 1998
Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraineA May, S L Shepheard, M Knorr, et al.
Cephalalgia : an International Journal of Headache|February 21, 2025
Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trialsPeter J Goadsby, Tim P Jürgens, Elimor Brand-Schieber, et al.
Headache|March 22, 2021
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysisAndrew M Blumenfeld, Peter J Goadsby, David W Dodick, et al.
Neurology|January 15, 2000
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering CommitteeP J Goadsby, M D Ferrari, J Olesen, et al.
Cephalalgia : an International Journal of Headache|September 7, 2011
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouseRammya Mathew, Anna P Andreou, Linda Chami, et al.
Headache|July 20, 2018
Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.
The Lancet. Neurology|February 21, 2023
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trialRichard B Lipton, Robert Croop, David A Stock, et al.
Pageof 92